Loading
INV-6452 is an experimental form not stated by the company or the registry from Shenzhen Ionova Life Sciences, in phase 1 trials for HR-positive HER2-negative breast cancer, ovarian cancer and endometrial cancer.
INV-6452 is a form not stated by the company or the registry (oral) from Shenzhen Ionova Life Sciences. Taken orally once daily in HR-positive, HER2-negative breast cancer and other solid tumours; no source found states its target or mechanism. Its furthest stage is phase 1, for HR-positive HER2-negative breast cancer, ovarian cancer and endometrial cancer. ClinicalTrials.gov registers it in one study linked below. Phase 1/2 first-in-human, recruiting, started 2025-07-04 (registry). Whether it works in people has not been established unless a trial below reports it.
Taken orally once daily in HR-positive, HER2-negative breast cancer and other solid tumours; no source found states its target or mechanism.
1.INV-6452 slips into a pocket on its target.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"INV-6452" OR ABSTRACT:"INV-6452") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about INV-6452, not a curated reading list.
Shares Shenzhen Ionova Life Sciences, Endometrial cancer, Ovarian cancer and the tag pipeline.
Shares Shenzhen Ionova Life Sciences, Endometrial cancer, Ovarian cancer and the tag pipeline.
Shares Endometrial cancer, Ovarian cancer and the tag pipeline.
Shares Shenzhen Ionova Life Sciences and the tag pipeline.
Shares Endometrial cancer, Ovarian cancer and the tag pipeline.
Shares Endometrial cancer, Ovarian cancer, HR-positive / HER2-negative breast cancer and the tag pipeline.
Shares Shenzhen Ionova Life Sciences and the tag pipeline.
Shares Shenzhen Ionova Life Sciences and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/